ronald virag ceti ~paris · ronald virag ceti ~paris . papavérine epigastric artery 2a 2b 2c...
TRANSCRIPT
Ronald Virag
CETI ~Paris
www.medisexe.com
Papavérine
Epigastric artery
2a
2b
2c
Clamp
The first intracavernous injection in february 1981
It happened during a Michal 1
procedure
Early pionneers 1976-1980
In the meantime in Paris…
Group 1: « Non organic »
Group 2: « Arterial »
Group 3: « Venous and Mixed
Giles S Brindley
1983/ Phenoxybenzamine
Adrian W Zorgniotti
1983/ Papaverine-Phentolamine
11
« CERITINE »
Papaverine
Alphablockers
Dipyramidole
Atropine
PGE1
J. of Urology 1991
Self IC injections of etilefrine
0
1000
2000
3000
4000
5000
6000
7000
Total
ICI
Over 7000 patients on Intracavernous Injections
Ronald Virag
CETI-Paris
H.Sussman, P.Bouilly, C.Daniel, K.Shoukry, F.Nollet,
C.Richard, J.Floresco, H.Saltiel, D.Frydman, C.Lévy
Et Catherine Arnion
Académie de Chirurgie~Séance du 5 mai 2010
Why do you prefer ICI ?
Sure/ No performance
anxiety
Longer erections
Stay after ejaculation
Very few side effects
The Present
Research
Treatment
Diagnosis
Pivotal role of IC pharma test
Oral
ICI
Surgery
Treatment of a symptom
Cure or Prevent a disease
• VEGF ENDOTHELIAL GENE THERAPY
• ADIPOSE TISSUE STEM CELL THERAPY
• ICI OF STEM CELLS FROM THE NEURAL CREST
• AUTOLOGOUS CELLULAR THERAPY
Compounds mixing
NO donnors + Calcium blockers +
K channel openers
Improvement of IC Routes
Guided molecules
Micropumps
CETI
A new promising treatment for ED and Lapeyronie’s disease
AUTOLOGOUS CELLULAR THERAPY
Traitement de la Maladie de Lapeyronie par PRP + HLA-
Early Results in 19 patients
Follow up
Mean follow up 11 months
12 > 6 months
Complication
One hematoma
15/19 patients improved (74%)
8 excellent (patient quotation)
7 fair
Unchanged or Worsened 2